Combination drug

Details for Australian Patent Application No. 2007307489 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Ohta, Yoshikazu; Tamura, Toshiya; Takagi, Shinji

Agent Griffith Hack

Pub. Number AU-A-2007307489

PCT Pub. Number WO2008/044782

Priority 2006-275841 06.10.06 JP; 2007-057902 07.03.07 JP

Filing date 5 October 2007

Wipo publication date 17 April 2008

International Classifications

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/4745 (2006.01)

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (1970.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/565 (1970.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/704 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/044782 Priority application(s): WO2008/044782

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007307504-Osteopenia animal model

2007307482-Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory